Agilent Technologiesvs.Waters Corporation
A vs WAT · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Agilent Technologies and Waters Corporation are similar in size by market cap; Agilent Technologies trades at the lower P/E (33.3 vs 255.2); year to date, Agilent Technologies leads (+24.3% vs +13.0%).
Side by side
| A | WAT | |
|---|---|---|
| Market cap | $48B | $42.4B |
| Price | $170.54 | $433.77 |
| Today | +1.4% | +1.1% |
| Return YTD | +24.3% | +13.0% |
| Return 1Y | +22.0% | +31.0% |
| Since June 26, 2026 | +25.4% | +15.9% |
| P/E | 33.3 | 255.2 |
| P/S | 6.5 | 9.1 |
| P/B | 6.5 | 2.8 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Agilent TechnologiesA
Laboratory analysis is the business: LC/MS and other analytical instruments, sold with the consumables and diagnostic reagents that keep them running.
Full A profile →Waters CorporationWAT
Waters sells liquid chromatography and mass spectrometry systems; pharmaceutical companies and other laboratories buy them along with the consumables and software that keep them running.
Full WAT profile →More A & WAT comparisons
Other head-to-heads in the Life science tools segment.